Literature DB >> 31734176

[Ketogenic diet as a trigger for diabetic euglycaemic ketoacidosis in a patient under treatment with iSGLT2].

A Nubiola1, A Ternianov2, I Remolins2.   

Abstract

Euglycaemic diabetic ketoacidosis is a possible adverse effect of selective sodium-glucose cotransporter inhibitors 2 (isGLT2) in patients with diabetes. However, the main scientific societies have recently recommended low or very low carbohydrate diets for the treatment of diabetes, relating the latter with the onset of ketosis. The combination of treatment with these drugs and following this type of diet can be dangerous. We present the case of a 64-year-old patient, suffering from LADA type diabetes, under usual treatment with intensive insulin therapy in 4 doses, who a few days after starting empagliflocin and a very low carbohydrate diet presented severe euglycaemic ketoacidotic decompensation.
Copyright © 2019. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Cetoacidosis; Diabetes mellitus de tipo 1; Dieta cetogénica; Empagliflocina; Empagliflozin; Euglucémica; Isglt2; Ketoacidosis; Ketodiet; Type 1 diabetes; Very low carb diet; iSGLT2

Year:  2019        PMID: 31734176     DOI: 10.1016/j.hipert.2019.09.003

Source DB:  PubMed          Journal:  Hipertens Riesgo Vasc        ISSN: 1889-1837


  4 in total

1.  Ketogenic Diet as a Trigger for Diabetic Ketoacidosis in a Misdiagnosis of Diabetes: A Case Report.

Authors:  Alexander J White-Cotsmire; Amber M Healy
Journal:  Clin Diabetes       Date:  2020-07

2.  Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective.

Authors:  Paras Kumar Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-17       Impact factor: 5.125

3.  Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i.

Authors:  Guillermo Velasco de Cos; María Isabel Sánchez-Molina Acosta; María Matilde Toval Fernández
Journal:  EJIFCC       Date:  2021-02-28

4.  Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin).

Authors:  Azka Latif; Aheli Arce Gastelum; Akshat Sood; Joseph Thilumala Reddy
Journal:  BMJ Case Rep       Date:  2020-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.